SII and Oxford University’s malaria vax launched in Côte d’Ivoire
The R21/Matrix-M malaria vaccine, co-developed by the Serum Institute of India (SII) and the University of Oxford, has been launched…
The R21/Matrix-M malaria vaccine, co-developed by the Serum Institute of India (SII) and the University of Oxford, has been launched…
AusperBio has raised $37m in a Series A financing round to propel the clinical development of AHB-1 for chronic hepatitis…
Sanofi and Biovac have announced a partnership to establish the first African-based manufacturing capabilities for inactivated polio vaccines (IPV), marking…
AstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex (fulvestrant) in the European Union (EU) for the treatment…
AstraZeneca has launched Evenova, a new digital health solutions business, within the company to expedite innovation in the life sciences industry. Evinova…
Bristol Myers Squibb (BMS) has received breakthrough therapy designation from the US Food and Drug Administration for its investigational therapy…
Arecor Therapeutics’ subsidiary Tetris Pharma has announced a commercialisation agreement with Goodlife for Ogluo. Under the exclusive agreement, Goodlife will…
Eden AcquisitionCo (Bidco) has signed an agreement to acquire British biopharmaceutical services company Ergomed in a deal valued at around…
Senju Pharmaceutical and Novaliq have closed a licence agreement for NOV03 (perfluorohexyloctane ophthalmic solution) to treat dry eye disease in…
The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of Pfizer’s…